Literature DB >> 26193832

Mesenchymal stem cells reverse trauma and hemorrhagic shock-induced bone marrow dysfunction.

Amy V Gore1, Letitia E Bible1, David H Livingston1, Alicia M Mohr1, Ziad C Sifri2.   

Abstract

BACKGROUND: Lung contusion (LC) followed by hemorrhagic shock (HS) causes persistent bone marrow (BM) dysfunction lasting up to 7 d after injury. Mesenchymal stem cells (MSCs) are multipotent cells that can hasten healing and exert protective immunomodulatory effects. We hypothesize that MSCs can attenuate BM dysfunction after combined LCHS.
MATERIALS AND METHODS: Male Sprague-Dawley rats (n = 5-6 per group) underwent LC plus 45 min of HS (mean arterial pressure of 30-35). Allogeneic MSCs (5 × 10(6) cells) were injected intravenously after resuscitation. At 7 d, BM was analyzed for cellularity and growth of hematopoietic progenitor cell (HPC) colonies (colony-forming unit-erythroid; burst-forming unit-erythroid; and colony-forming unit-granulocyte, erythrocyte, monocyte, megakaryocyte). Flow cytometry measured %HPCs in peripheral blood; plasma granulocyte colony-stimulating factor (G-CSF) levels were measured via enzyme-linked immunosorbent assay. Data were analyzed by one-way analysis of variance followed by the Tukey multiple comparison test.
RESULTS: As previously shown, at 7 d, LCHS resulted in 22%, 30%, and 24% decreases in colony-forming unit-granulocyte, erythrocyte, monocyte, megakaryocyte, burst-forming unit-erythroid, and colony-forming unit-erythroid colony growth, respectively, versus naive. Treatment with MSCs returned all BM parameters to naive levels. There was no difference in %HPCs in peripheral blood between groups; however, G-CSF remained increased up to 7 d after LCHS. MSCs returned G-CSF to naive levels. Plasma from animals receiving MSCs was not suppressive to the BM.
CONCLUSIONS: One week after injury, the persistent BM dysfunction observed in animals undergoing LCHS is reversed by treatment with MSCs with an associated return of plasma G-CSF levels to normal. Plasma from animals undergoing LCHS plus MSCs was not suppressive to BM cells in vitro. Treatment with MSCs after injury and shock reverses BM suppression and returns plasma G-CSF levels to normal.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  G-CSF; Hematopoietic progenitor cells; Hemorrhagic shock; Mesenchymal stem cells; Trauma

Mesh:

Substances:

Year:  2015        PMID: 26193832      PMCID: PMC4636953          DOI: 10.1016/j.jss.2015.06.023

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  22 in total

1.  Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.

Authors:  M K Majumdar; M A Thiede; J D Mosca; M Moorman; S L Gerson
Journal:  J Cell Physiol       Date:  1998-07       Impact factor: 6.384

2.  β-blockade protection of bone marrow following trauma: the role of G-CSF.

Authors:  Gregg M Baranski; Michael D Offin; Ziad C Sifri; Ihab O Elhassan; Edward J Hannoush; Walter D Alzate; Pranela Rameshwar; David H Livingston; Alicia M Mohr
Journal:  J Surg Res       Date:  2011-04-19       Impact factor: 2.192

3.  Beta-blockade prevents hematopoietic progenitor cell suppression after hemorrhagic shock.

Authors:  Ihab O Elhassan; Edward J Hannoush; Ziad C Sifri; Eyone Jones; Walter D Alzate; Pranela Rameshwar; David H Livingston; Alicia M Mohr
Journal:  Surg Infect (Larchmt)       Date:  2011-07-26       Impact factor: 2.150

4.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

Authors:  Yoshinori Miyahara; Noritoshi Nagaya; Masaharu Kataoka; Bobby Yanagawa; Koichi Tanaka; Hiroyuki Hao; Kozo Ishino; Hideyuki Ishida; Tatsuya Shimizu; Kenji Kangawa; Shunji Sano; Teruo Okano; Soichiro Kitamura; Hidezo Mori
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

5.  Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice.

Authors:  Dong Hyun Kim; Keon Hee Yoo; Young Sook Yim; Jaewon Choi; Soo Hyun Lee; Hye Lim Jung; Ki Woong Sung; Sung-Eun Yang; Won Il Oh; Yoon-Sun Yang; Sang-Hee Kim; Sang-Yun Choi; Hong Hoe Koo
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

Review 6.  Transfusion practice in the critically ill.

Authors:  Howard L Corwin; Stephen D Surgenor; Andrew Gettinger
Journal:  Crit Care Med       Date:  2003-12       Impact factor: 7.598

7.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

8.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies.

Authors:  S E Haynesworth; M A Baber; A I Caplan
Journal:  Bone       Date:  1992       Impact factor: 4.398

9.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

Review 10.  Why are MSCs therapeutic? New data: new insight.

Authors:  A I Caplan
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

View more
  4 in total

Review 1.  Trauma and Stem Cells: Biology and Potential Therapeutic Implications.

Authors:  Kabilan Thurairajah; Matthew L Broadhead; Zsolt J Balogh
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

Review 2.  Therapeutic Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Prevention of Organ Injuries Induced by Traumatic Hemorrhagic Shock.

Authors:  Guillaume Valade; Nicolas Libert; Christophe Martinaud; Eric Vicaut; Sébastien Banzet; Juliette Peltzer
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

3.  Scanning Probe Microscopy Bone Marrow Determination of Steogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Xiandong Fu; Qixin Lian; Bo Zhang; Xinli Teng; Ying Chen; Yikun Qu; Zhuoxin Cheng; Linqi Guo
Journal:  Contrast Media Mol Imaging       Date:  2022-07-08       Impact factor: 3.009

Review 4.  Mesenchymal Stem Cells after Polytrauma: Actor and Target.

Authors:  Markus Huber-Lang; Rebecca Wiegner; Lorenz Lampl; Rolf E Brenner
Journal:  Stem Cells Int       Date:  2016-06-02       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.